The Background: The Ministry of Health, Labour and Welfare ("the MHLW") currently lacks sufficient legal experience to assess whether a generic product will, if approved, infringe a third-party patent ...
“Despite the limitations imposed by the Bolar Exemption on protecting patent holders, Brazilian litigants have been exploring alternative strategies to ensure market exclusivity for innovators.” ...